Ovid therapeutics inc shareholders eligible to participate in fraud investigation with schall law firm

Los angeles, ca / accesswire / august 17, 2024 / the schall law firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ovid therapeutics inc. ("ovid" or "the company") (nasdaq:ovid) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
OVID Ratings Summary
OVID Quant Ranking